Bosh sahifaSRPT • NASDAQ
add
Sarepta Therapeutics Inc
148,98 $
Seans yopilganidan keyin:(0,58%)-0,86
148,12 $
Yopilgan:16-iyl, 19:20:54 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
152,67 $
Kunlik diapazon
148,37 $ - 153,30 $
Yillik diapazon
55,25 $ - 173,25 $
Bozor kapitalizatsiyasi
14,08 mlrd USD
Oʻrtacha hajm
2,52 mln
Narx/foyda
1 869,96
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 413,46 mln | 63,10% |
Joriy xarajat | 127,60 mln | 15,07% |
Sof foyda | 36,12 mln | 106,99% |
Sof foyda marjasi | 8,74 | 104,29% |
Har bir ulushga tushum | 0,73 | 175,26% |
EBITDA | 43,65 mln | 134,43% |
Amaldagi soliq stavkasi | 12,86% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,39 mlrd | -26,11% |
Jami aktivlari | 3,22 mlrd | 5,38% |
Jami passivlari | 2,26 mlrd | -3,57% |
Umumiy kapital | 961,19 mln | — |
Tarqatilgan aksiyalar | 94,52 mln | — |
Narxi/balansdagi bahosi | 15,01 | — |
Aktivlardan daromad | 2,69% | — |
Kapitaldan daromad | 3,78% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 36,12 mln | 106,99% |
Operatsiyalardan naqd pul | -242,08 mln | -15,61% |
Sarmoyadan naqd pul | 218,80 mln | 1 651,49% |
Moliyadan naqd pul | 22,14 mln | -78,25% |
Naqd pulning sof oʻzgarishi | -1,14 mln | 98,80% |
Boʻsh pul | -188,32 mln | -10,98% |
Haqida
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
Tashkil etilgan
1980
Sayt
Xodimlar soni
1 314
